Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis

por Bai, Long, Wang, Feng, Li, Zhe-zhen, Ren, Chao, Zhang, Dong-sheng, Zhao, Qi, Lu, Yun-xin, Wang, De-shen, Ju, Huai-qiang, Qiu, Miao-zhen, Wang, Zhi-qiang, Wang, Feng-hua, Xu, Rui-hua
Publicado 2016

Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response

por Li, Zhe-Zhen, Wang, Feng, Zhang, Zi-Chen, Wang, Fang, Zhao, Qi, Zhang, Dong-Sheng, Wang, Feng-Hua, Wang, Zhi-Qiang, Luo, Hui-Yan, He, Ming-Ming, Wang, De-Shen, Jin, Ying, Ren, Chao, Qiu, Miao-Zhen, Ren, Jian, Pan, Zhi-Zhong, Li, Yu-Hong, Shao, Jiao-Yong, Xu, Rui-Hua
Publicado 2016